Sijie Lu

1.7k total citations · 1 hit paper
25 papers, 1.3k citations indexed

About

Sijie Lu is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Sijie Lu has authored 25 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Immunology, 8 papers in Oncology and 7 papers in Molecular Biology. Recurrent topics in Sijie Lu's work include Immunotherapy and Immune Responses (13 papers), CAR-T cell therapy research (7 papers) and Acute Myeloid Leukemia Research (5 papers). Sijie Lu is often cited by papers focused on Immunotherapy and Immune Responses (13 papers), CAR-T cell therapy research (7 papers) and Acute Myeloid Leukemia Research (5 papers). Sijie Lu collaborates with scholars based in United States, China and Japan. Sijie Lu's co-authors include Nicholas P. Restifo, Yeonseok Chung, Xuexian O. Yang, Natalia Martín‐Orozco, Tomohide Yamazaki, Chen Dong, Pawel Muranski, Patrick Hwu, Willem W. Overwijk and Jeffrey J. Molldrem and has published in prestigious journals such as Journal of Clinical Investigation, Blood and Immunity.

In The Last Decade

Sijie Lu

20 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

T Helper 17 Cells Promote Cytotoxic T Cell Activation in Tumor Immunity

2009 618 citations Natalia Martín‐Orozco, Pawel Muranski et al. Immunity profile →

Peers

Countries citing papers authored by Sijie Lu

Since Specialization

Citations

This map shows the geographic impact of Sijie Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sijie Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sijie Lu more than expected).

Fields of papers citing papers by Sijie Lu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sijie Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sijie Lu. The network helps show where Sijie Lu may publish in the future.

Co-authorship network of co-authors of Sijie Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Sijie Lu. A scholar is included among the top collaborators of Sijie Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sijie Lu. Sijie Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Assessing the Ecosystem Service Value of Small-Scale Landscapes in Rural Tourism Destinations in the Yangtze River Delta 2025 ·Sustainability ·(unknown), Sijie Lu, Yue Ji, (unknown), Guangming He	0
2	Extracorporeal membrane oxygenation in pregnancy and the post-partum period: a systematic review and meta-analysis 2025 ·The Journal of Maternal-Fetal & Neonatal Medicine ·Sijie Lu, (unknown), (unknown), Jian Li, Mingming Li, Junjie Ying, Dezhi Mu, Yujun Shi, Yongnan Li, X. Wu	2
3	Effectiveness of exercise-based cardiac rehabilitation for patients with left ventricular assist device: A systematic review and meta-analysis 2024 ·Perfusion ·Yujin Wang, (unknown), (unknown), Sijie Lu, (unknown), Yanchun Zhang, Xiangyang Wu, Xiaowei Zhang, Yongnan Li	0
4	Hu8F4-CAR T cells with mutated Fc spacer segment improve target specificity and mediate anti-leukemia activity in vivo 2024 ·Cytotherapy ·(unknown), (unknown), Sijie Lu, Qiaochuan Li, (unknown), Lisa S. St. John, Анна Сергеева, Karen Clise-Dwyer, Gheath Alatrash, Elizabeth J. Shpall, Qing Ma, Jeffrey J. Molldrem	1
5	Novel myeloperoxidase-derived HLA-A2-restricted peptides as therapeutic targets against myeloid leukemia 2021 ·Cytotherapy ·Sijie Lu, (unknown), Xiaoling Ding, Dan Li, (unknown), M. James You, Lisa S. St. John, Gheath Alatrash, Qing Ma, Jeffrey J. Molldrem	1
6	Two unique HLA-A0201 restricted peptides derived from cyclin E as immunotherapeutic targets in leukemia 2020 ·Leukemia* ·Hong He, Yukio Kondo, Ken Ishiyama, Gheath Alatrash, Sijie Lu, (unknown), Na Qiao, Karen Clise-Dwyer, Lisa S. St. John, Pariya Sukhumalchandra, Qing Ma, Jeffrey J. Molldrem	9
7	A Novel HLA-A0201 Restricted Peptide Derived from Cathepsin G Is an Effective Immunotherapeutic Target in Acute Myeloid Leukemia 2020 ·UNC Libraries* ·Tania Rodríguez-Cruz, Jeffrey J. Molldrem, Pariya Sukhumalchandra, Sally A. Hunsucker, Elizabeth A. Mittendorf, Kathryn Ruisaard, (unknown), Gregory Lizée, Gheath Alatrash, Paul M. Armistead, Karen Clise-Dwyer, (unknown), Patricia A. Ropp, Zein Al-Atrache, (unknown), (unknown), Sijie Lu, Lisa S. St. John, Gary L. Glish	0
8	A Novel T-Cell Engaging Bi-specific Antibody Targeting the Leukemia Antigen PR1/HLA-A2 2019 ·Frontiers in Immunology ·(unknown), Jin S. Im, Sumedha Pareek, (unknown), Sijie Lu, Анна Сергеева, Jennifer Mehrens, Hong He, Gheath Alatrash, Pariya Sukhumalchandra, Lisa S. St. John, Karen Clise-Dwyer, Dongxing Zha, Jeffrey J. Molldrem	13
9	Identification of Myeloperoxidase As a Leukemia-Associated Antigen and Therapeutic Target for Acute Myeloid Leukemia 2017 ·Blood ·(unknown), Sijie Lu, Xiaoling Ding, Dan Li, Kathryn Ruisaard, M. James You, Lisa S. St. John, Gheath Alatrash, Qing Ma, Jeffrey J. Molldrem	0
10	A novel TCR-like CAR with specificity for PR1/HLA-A2 effectively targets myeloid leukemia in vitro when expressed in human adult peripheral blood and cord blood T cells 2016 ·Cytotherapy ·Qing Ma, Haven R. Garber, Sijie Lu, Hong He, (unknown), Xiaoling Ding, Анна Сергеева, Michael S. Wood, Gianpietro Dotti, (unknown), Kathryn Ruisaard, Karen Clise-Dwyer, Lisa S. St. John, Katayoun Rezvani, Gheath Alatrash, Elizabeth J. Shpall, Jeffrey J. Molldrem	74
11	Breast Cancer Cell Uptake of the Inflammatory Mediator Neutrophil Elastase Triggers an Anticancer Adaptive Immune Response 2012 ·Cancer Research ·Elizabeth A. Mittendorf, Gheath Alatrash, Na Qiao, Yun Wu, Pariya Sukhumalchandra, Lisa S. St. John, Anne V. Philips, (unknown), (unknown), Kathryn Ruisaard, Karen Clise-Dwyer, Sijie Lu, Jeffrey J. Molldrem	72
12	A Novel HLA-A0201 Restricted Peptide Derived from Cathepsin G Is an Effective Immunotherapeutic Target in Acute Myeloid Leukemia 2012 ·Clinical Cancer Research* ·Mao Zhang, Pariya Sukhumalchandra, (unknown), Lisa S. St. John, Sally A. Hunsucker, Elizabeth A. Mittendorf, Анна Сергеева, Kathryn Ruisaard, Zein Al-Atrache, Patricia A. Ropp, (unknown), Tania Rodríguez-Cruz, Gregory Lizée, Karen Clise-Dwyer, Sijie Lu, Jeffrey J. Molldrem, Gary L. Glish, Paul M. Armistead, Gheath Alatrash	19
13	The Role of Antigen Cross-presentation From Leukemia Blasts on Immunity to the Leukemia-associated Antigen PR1 2012 ·Journal of Immunotherapy ·Gheath Alatrash, Yoko Ono, Анна Сергеева, Pariya Sukhumalchandra, Mao Zhang, Lisa S. St. John, (unknown), Kathryn Ruisaard, Paul M. Armistead, Elizabeth A. Mittendorf, Hong He, Na Qiao, Tania Rodríguez-Cruz, Shoudan Liang, Karen Clise-Dwyer, Eric Wieder, Gregory Lizée, Sijie Lu, Jeffrey J. Molldrem	19
14	An anti–PR1/HLA-A2 T-cell receptor–like antibody mediates complement-dependent cytotoxicity against acute myeloid leukemia progenitor cells 2011 ·Blood ·Анна Сергеева, Gheath Alatrash, Hong He, Kathryn Ruisaard, Sijie Lu, James N. Wygant, Bradley W. McIntyre, Qing Ma, (unknown), Lisa S. St. John, Karen Clise-Dwyer, Jeffrey J. Molldrem	91
15	PR1-Specific T Cells Are Associated with Unmaintained Cytogenetic Remission of Chronic Myelogenous Leukemia After Interferon Withdrawal 2010 ·PLoS ONE ·Shreya Kanodia, Eric Wieder, Sijie Lu, Moshe Talpaz, Gheath Alatrash, Karen Clise-Dwyer, Jeffrey J. Molldrem	24
16	Adoptive transfer of PR1 cytotoxic T lymphocytes associated with reduced leukemia burden in a mouse acute myeloid leukemia xenograft model 2010 ·Cytotherapy ·Qing Ma, Changqing Wang, Dan Jones, (unknown), Dan Li, Yang Wang, Eric Wieder, Karen Clise-Dwyer, Gheath Alatrash, (unknown), Mark F. Munsell, Sijie Lu, Muzaffar H. Qazilbash, Jeffrey J. Molldrem	27
17	T Helper 17 Cells Promote Cytotoxic T Cell Activation in Tumor Immunity breakdown → 2009 ·Immunity ·Natalia Martín‐Orozco, Pawel Muranski, Yeonseok Chung, Xuexian O. Yang, Tomohide Yamazaki, Sijie Lu, Patrick Hwu, Nicholas P. Restifo, Willem W. Overwijk, Chen Dong	618
18	PR1 Vaccine Elicited Immunological Response after Hematopoietic Stem Cell Transplantation Is Associated with Better Clinical Response and Event-Free Survival. 2007 ·Blood ·Muzaffar H. Qazilbash, Eric Wieder, Peter F. Thall, Xuemei Wang, (unknown), Sijie Lu, Shreya Kant, Sergio Giralt, Elihu H. Estey, Jörge E. Cortes, Krishna V. Komanduri, Richard E. Champlin, Jeffrey J. Molldrem	19
19	PR1 Peptide Vaccine-Induced Immune Response Is Associated with Better Event-Free Survival in Patients with Myeloid Leukemia. 2007 ·Blood ·Muzaffar H. Qazilbash, Eric Wieder, Peter F. Thall, Xuemei Wang, (unknown), Sijie Lu, Shreya Kant, Sergio Giralt, Elihu H. Estey, Jörge E. Cortes, Krishna V. Komanduri, Richard E. Champlin, Jeffrey J. Molldrem	27
20	Chronic myelogenous leukemia shapes host immunity by selective deletion of high-avidity leukemia-specific T cells 2003 ·Journal of Clinical Investigation ·Jeffrey J. Molldrem, Peter P. Lee, Shreya Kant, Eric Wieder, Weidong Jiang, Sijie Lu, Changqing Wang, Mark M. Davis	45

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact